The NVIDIA-Powered AI Drug Discovery Ecosystem Across the globe, innovators are building the future of AI for drug discovery ...

Researchers from the Department of Energy's SLAC National Accelerator Laboratory and the University of California, Los ...

Global chipmaker giant NVIDIA kicked off JPM Week with several partnership announcements, most notably a billion dollar ...

For decades, the process of drug discovery has been a prolonged, costly, and unpredictable endeavor — an effort that ...

Arun Subramaniyan, a leader in enterprise AI, is now heading Articul8, a company focused on orchestrating specialized AI ...

Nvidia (NASDAQ:NVDA) expanded its BioNeMo platform with new models, tools and data-processing libraries aimed at connecting ...

This important study introduces a new biology-informed strategy for deep learning models aiming to predict mutational effects in antibody sequences. It provides solid evidence that separating ...

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease, and if it is accurately predicted ...

S4GA challenged the cabling status quo with its Solar CAT I technology. After winning the Innovation Award in Munich, the ...

Fluid–structure interaction (FSI) governs how flowing water and air interact with marine structures—from wind turbines to ...

The scientists behind the MAGIS-100 experiment aim to use state-of-the-art lasers to shed light on ultralight dark matter.

For the first time, physicists in Italy have created a 'lump soliton': an extremely stable packet of light waves which can ...